Paradigm Biopharmaceuticals Limited (PAR.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 0.2850 |
| Open | 0.2900 |
| Bid | 0.2700 x 250400 |
| Ask | 0.2800 x 1420100 |
| Day's range | 0.2700 - 0.2950 |
| 52-week range | 0.2650 - 1.0651 |
| Volume | |
| Avg. volume | 654,560 |
| Market cap | 94.755M |
| Beta (5Y monthly) | 0.96 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2300 |
| Earnings date | 28 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.36 |
PR NewswireHope for knee osteoarthritis sufferers with advent of global clinical trial.
With the launch of a new website dedicated to their global clinical trials (https://hope4OA.com), Paradigm Biopharmaceuticals Ltd. (Paradigm Biopharma) aims to provide relief to millions of osteoarthritis (OA) sufferers worldwide by developing a new injectable drug.
© 2024 Yahoo. All rights reserved.